|Kevin Kim, MD|
Director of Clinical Trials
|Patricia Fugal, MS, CCRP|
|Eliot Funai, CCRP|
|Svetlana Vassilieva, MD, MS|
Senior Clinical Research Specialist
|Cynthia Voghell BS|
TIMC Technical Coordinator
|Teresa White, BSN, OCN,CCRP|
Clinical Research Nurse
TUMOR IMAGING METRICS CORE - TIMC
The mission of TIMC is to provide standardized, longitudinal radiological measurements to evaluate therapeutic responses for clinical trials
TIMC tracks changes in tumor measurements per study protocol, which is essential for clinical trials that use radiological measurements as surrogate endpoints. The system manages these images and takes measurements in a routine and centralized method.
We support an array of services in addition to traditional research coordination. The Clinical Trials Office also has a key role in supporting investigators with grant applications and submissions.
Interventional Oncology and Clinical Trials
TheGeschwind Lab is comprised of a team of faculty, post-doctorate researchers, scientists, medical students, residents, and fellows all with the goal of furthering research in interventional oncology by improving the detection, characterization, and treatment of cancers in the liver. This includes research in basic science developing anti-cancer therapies; translational pre-clinical research bringing innovations from the laboratory to clinical use; clinical clinicalm, research on improving current intra-arterial therapies and procedural imaging; and clinical trials that offer new treatment options for patients with liver cancer, including hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, and liver metastases from a secondary cancer.
For more information please view current diagnostic and interventional radiology trials; https://medicine.yale.edu/cancer/patient/trials/
Imaging Support Services
Imaging Support Services, ISS, manages the imaging components of the Yale Cancer Center’s clinical trials from budget and feasibility through close out. Staff reviews sponsor and cooperative group protocols, imaging acquisition guidelines, and imaging manuals to identify standard and non-standard imaging to ensure feasibility. This includes determining the appropriate fees and imaging resources for project completion, completing the image transfer out of PACs to the sponsors for all disease teams, and serving as the primary contact for sponsors and central vendors. ISS also manages the clinical research radiology approvals for non-standard imaging/pricing and assists in coordinating YCC biopsies for IR.
Research Trials Utilizing Imaging Scans:
All research studies utilizing Diagnostic Imaging hospital/affiliated facilities imaging equipment or research studies requesting a Diagnostic Radiology clinical services and clinical research coordinator must be reviewed and approved by the YDR CTO Committee*. All investigators must complete this YDRCTO form (there is a single approval process for both YNHH and the university department).
*Note: Imaging research performed at the MRRC or Research PET Centers is reviewed separately and under the jurisdiction of the Division of Bioimaging Sciences.